ArticleCell death & disease2024

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer.

Josephina Sampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.